Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Cholinesterase inhibitors in Alzheimer's disease: Final report; commission A05-19A. February 07, 2007. (IQWiG reports; Volume 17).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Update search on report A05-19A (cholinesterase inhibitors in the treatment of Alzheimer's Disease) 2009.
Strohle A, Schmidt DK, Schultz F, Fricke N, Staden T, Hellweg R et al. Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials. Am J Geriatr Psychiatry 2015; 23(12): 1234-1249.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.